REG-BARCLAYS PLC Form 8.3 - Willis Towers Watson plc
16/07/2021 13:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210716:nBw89KdVta&default-theme=true
Form 8.3 - Willis Towers Watson plc
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 15 July 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,883,045 1.46% 240,322 0.19%
(2) Derivatives (other than options):
72,359 0.06% 227,408 0.18%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,961,504 1.52% 473,830 0.37%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 4 223.3400 USD
Purchase 11 222.4700 USD
Purchase 22 223.1300 USD
Purchase 46 221.8100 USD
Purchase 100 223.2050 USD
Purchase 100 222.0700 USD
Purchase 200 222.7300 USD
Purchase 241 221.8200 USD
Purchase 810 222.5472 USD
Purchase 1,100 223.3169 USD
Purchase 1,569 222.5755 USD
Purchase 2,054 222.6853 USD
Purchase 2,477 222.8360 USD
Purchase 2,796 222.1468 USD
Purchase 2,811 221.9100 USD
Purchase 7,377 223.0088 USD
Purchase 7,527 221.9333 USD
Purchase 11,780 223.4663 USD
Purchase 19,976 222.5297 USD
Sale 1 224.5800 USD
Sale 1 224.6000 USD
Sale 2 222.5800 USD
Sale 7 221.7000 USD
Sale 45 223.0566 USD
Sale 93 223.0300 USD
Sale 99 224.3800 USD
Sale 100 223.3300 USD
Sale 100 223.0500 USD
Sale 100 223.0900 USD
Sale 100 223.0600 USD
Sale 157 223.2371 USD
Sale 200 222.7300 USD
Sale 260 223.1653 USD
Sale 300 223.6916 USD
Sale 400 223.3175 USD
Sale 420 223.1635 USD
Sale 479 222.6546 USD
Sale 1,000 224.2540 USD
Sale 1,098 222.8343 USD
Sale 1,100 223.3169 USD
Sale 1,103 223.2834 USD
Sale 1,152 221.9149 USD
Sale 1,379 222.8373 USD
Sale 1,452 224.3242 USD
Sale 1,569 222.5755 USD
Sale 1,631 221.9100 USD
Sale 3,296 222.1903 USD
Sale 4,310 222.9748 USD
Sale 7,527 221.9333 USD
Sale 8,300 223.2332 USD
Sale 23,227 222.5333 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 16 Jul 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210716005207/en/
(https://www.businesswire.com/news/home/20210716005207/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Greencore Group PLC - Form 8.3 GREENCORE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement